West Suffield, CT, United States of America

Donna Marie Barten

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Donna Marie Barten: Innovator in Tau-Associated Disease Treatment

Introduction

Donna Marie Barten is a notable inventor based in West Suffield, CT (US). She has made significant contributions to the field of medicine, particularly in the treatment of Tau-associated diseases, including Alzheimer's disease. Her innovative approach has led to the development of effective therapies that address these challenging conditions.

Latest Patents

Barten holds a patent for the "Use of epothilone D in treating Tau-associated diseases." This patent describes methods of treating tauopathies using epothilone D, which exhibits good brain penetration, a long half-life, and high selective retention in the brain. These properties make it a promising candidate for effective therapies in treating tauopathies, including Alzheimer's disease.

Career Highlights

Barten is associated with Bristol-Myers Squibb Company, where she has been instrumental in advancing research and development in her field. Her work has garnered attention for its potential impact on the treatment of neurodegenerative diseases.

Collaborations

Throughout her career, Barten has collaborated with esteemed colleagues, including Charles F. Albright and Francis Lee. These partnerships have contributed to the advancement of her research and the development of innovative treatment methods.

Conclusion

Donna Marie Barten's contributions to the treatment of Tau-associated diseases highlight her role as a leading inventor in the medical field. Her innovative work continues to pave the way for new therapies that can improve the lives of those affected by Alzheimer's disease and other tauopathies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…